Lexicon Pharmaceuticals

LXRX · NASDAQ

$1.58+$0.03 (+1.94%)TodayMarket closed · Oct 20, 7:50 PM ET

Prev close $1.55

Latest news

NewsOct 6, 3:51 AM ET
Lexicon Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript
NewsSep 16, 8:01 AM ETAvi Kapoor
Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Press releaseAug 31, 8:30 AM ETGlobe Newswire
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure
Press releaseAug 24, 8:30 AM ETGlobe Newswire
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
NewsAug 6, 7:48 AM ET
Lexicon Pharmaceuticals Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $692.000K Miss $3.998M Estimate
Press releaseAug 6, 7:30 AM ETGlobe Newswire
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Press releaseJul 27, 8:30 AM ETGlobe Newswire
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
Press releaseJun 3, 8:00 AM ETGlobe Newswire
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
NewsMay 11, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseMay 7, 7:30 AM ETGlobe Newswire
Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates
Press releaseMay 4, 4:05 PM ETGlobe Newswire
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
Press releaseApr 17, 8:00 AM ETGlobe Newswire
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
Press releaseMar 24, 8:00 AM ETGlobe Newswire
Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
NewsMar 5, 7:02 AM ET
Lexicon Pharmaceuticals Q4 Earnings Summary & Key Takeaways
NewsMar 5, 6:11 AM ET
Earnings Scheduled For March 5, 2026
NewsMar 4, 12:03 PM ET
Exploring Lexicon Pharmaceuticals's Earnings Expectations
Press releaseMar 3, 5:31 PM ETPRNewswire
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
NewsJan 30, 12:05 PM ETAvi Kapoor
Gold Tumbles Over 6%; Apple Posts Upbeat Earnings
NewsJan 21, 10:19 AM ETAvi Kapoor
Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On Wednesday
Press releaseJan 20, 6:59 AM ETPRNewswire
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
NewsNov 28, 8:17 AM ETAvi Kapoor
Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
NewsNov 17, 8:15 AM ETAvi Kapoor
Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsSep 29, 8:06 AM ETAvi Kapoor
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
NewsMay 12, 2:09 PM ET
A Preview Of Lexicon Pharmaceuticals's Earnings
NewsMar 31, 5:29 AM ETRishabh Mishra
US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
NewsMar 28, 2:00 PM ET
What 6 Analyst Ratings Have To Say About Lexicon Pharmaceuticals
NewsMar 28, 9:02 AM ETVandana Singh
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
NewsMar 7, 8:00 AM ET
What Analysts Are Saying About Lexicon Pharmaceuticals Stock
NewsJan 29, 7:00 AM ET
Lexicon Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
NewsJan 28, 12:35 PM ET
9 Health Care Stocks With Whale Alerts In Today's Session
Press releaseJan 21, 8:00 AM ETGlobe Newswire
Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain
NewsDec 23, 7:00 AM ET
Analyst Expectations For Lexicon Pharmaceuticals's Future
NewsNov 13, 7:00 AM ET
Demystifying Lexicon Pharmaceuticals: Insights From 10 Analyst Reviews
NewsNov 11, 10:01 AM ET
Preview: Lexicon Pharmaceuticals's Earnings
NewsNov 5, 2:01 PM ET
The Analyst Landscape: 11 Takes On Lexicon Pharmaceuticals
NewsNov 1, 2:35 PM ETAvi Kapoor
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results
NewsNov 1, 12:26 PM ETAvi Kapoor
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
NewsNov 1, 10:43 AM ETAvi Kapoor
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
NewsNov 1, 9:15 AM ETAvi Kapoor
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
NewsNov 1, 9:05 AM ETVandana Singh
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
NewsNov 1, 8:11 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsNov 1, 8:11 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsOct 23, 10:01 AM ET
Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)
Press releaseOct 16, 4:34 PM ETPRNewswire
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Lexicon Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript

Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

Lexicon Pharmaceuticals Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $692.000K Miss $3.998M Estimate

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

12 Health Care Stocks Moving In Monday's Intraday Session

Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting

Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo

Lexicon Pharmaceuticals Q4 Earnings Summary & Key Takeaways

Earnings Scheduled For March 5, 2026

Exploring Lexicon Pharmaceuticals's Earnings Expectations

Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight

Gold Tumbles Over 6%; Apple Posts Upbeat Earnings

Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On Wednesday

Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure

Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Earnings Scheduled For November 6, 2025

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

A Preview Of Lexicon Pharmaceuticals's Earnings

US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst

What 6 Analyst Ratings Have To Say About Lexicon Pharmaceuticals

Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk

What Analysts Are Saying About Lexicon Pharmaceuticals Stock

Lexicon Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

9 Health Care Stocks With Whale Alerts In Today's Session

Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain

Analyst Expectations For Lexicon Pharmaceuticals's Future

Demystifying Lexicon Pharmaceuticals: Insights From 10 Analyst Reviews

Preview: Lexicon Pharmaceuticals's Earnings

The Analyst Landscape: 11 Takes On Lexicon Pharmaceuticals

Crude Oil Moves Higher; Apple Shares Slide After Q4 Results

Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results

Dow Jumps 400 Points; US Adds 12,000 Jobs In October

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe